In contrast, ACEI or ARB may down‐regulate vascular endothelial growth factor‐mediated angiogenesis through angiotensin II and angiotensin receptors, which could potentially have anti‐cancer effects for skin, urogenital, or breast cancers [36, 37, 38]. The gene discussed is AGT; the disease is breast carcinoma.